in a rheumatology position? If so, will I simply be a layover rep for some existing BMS reps who sell Orencia 1st and I come along and clean up with Otezla? I understand that dermatology is fine and I get that, but I'd really rather stay with my existing customers in rheumatology but if I am only going to be a layover I'd rather go on over to MS, even if the drug is #25 in crowded market with no differentiation.
It won’t be your choice to move over to MS. Those spots will be for very high ranked reps and preferably reps with MS experience. Not to mention Celgene won’t be in charge of hiring the ozanimod reps, BMS will.
Exactly, I also don’t get all the OZ promotions to marketing and regional positions. Won’t BMS want to pick those?
Who says Derm is fine? Just because BMS doesn’t have a derm division doesn’t mean all the derm reps are okay. They could end up combining territories, making hybrid reps, completely hire from within. We have no idea what’s going to happen. Just gotta wait it out. Whatever happens though don’t worry. The severance is amazing either way.
sorry, no. BMS want the product to get approve and hum. period. For that to happened, things really need to happen on the back end between the end of March 19 and about November this year. After that, it's just adjustments. BMS can't wait until the deal closes, then wait more for DayOne, then more for integration or the game is already over.
From an employee law perspective it’s easier for BMS to let us all go. BMS will have territories drawn up and where they have a vacancy, we can interview. Many will land on our feet in derm/rheum because that division is small at BMS.
